MARATTO

article · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Unlocking the therapeutic potential of canagliflozin in NAFLD: Insights into AMPK/SIRT1-mediated lipophagy

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Liver Disease Diagnosis and Treatment
  • Diabetes Treatment and Management
  • Diabetes, Cardiovascular Risks, and Lipoproteins

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.bbadis.2025.167666

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.